MECHANISMS OF ACQUIRED RESISTANCE TO CETUXIMAB: ROLE OF HER (ErbB) FAMILY MEMBERS

The epidermal growth factor receptor (EGFR) is a central regulator of proliferation and progression in human cancers. Five EGFR inhibitors, two monoclonal antibodies and three TKIs, have recently gained FDA approval in oncology (cetuximab, panitumumab, erlotinib, gefitinib and lapatinib). These stra...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Wheeler, Deric L., Huang, Shyhmin, Kruser, Tim J., Nechrebecki, Meghan M., Armstrong, Eric A., Benavente, Sergio, Gondi, Vinai, Hsu, Kun-Tai, Harari, Paul M.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2008
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2903615/
https://ncbi.nlm.nih.gov/pubmed/18297114
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2008.19
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge